Remove market-access deep-dive
article thumbnail

Regional inequalities threatening Europe’s biosimilars market

European Pharmaceutical Review

The report noted that biosimilar adoption levels vary significantly across Europe because of differences in baseline use of biologics, biosimilar reimbursement, procurement, policies, and education, based on research published in a paper in the Journal of Market Access & Health Policy in 2017.

article thumbnail

Deep Dive: Digital Health 2022

pharmaphorum

With myriad new technologies and tools hitting the market, there is no doubt that digital health is transforming the way that we deliver and receive healthcare. However, as the market begins to correct itself, where does digital health go from here? Read Deep Dive: Digital Health 2022 in full.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Unlocking the potential of connected commercialisation solutions

pharmaphorum

For life science companies, it is more important than ever to understand the market access landscape they are launching in and review how commercial and engagement strategies align with the needs of today’s customers.

article thumbnail

Gene therapies for prevalent diseases in Europe – the perfect storm of economic sustainability?

pharmaphorum

In this article, Research Partnership reviews why the path to commercialisation for the half a dozen approvals in Europe over the last few years has not been smooth, and shares feedback gathered from our payer network on the outlook for gene therapy market access in Europe, especially considering the shift to more prevalent diseases.

article thumbnail

Co-creating a patient engagement impact framework

pharmaphorum

Regulatory and market access submissions. Here, we examine how patients view the impact from projects and their experiences of discussing impact measurement with life science companies. • Read the full article in pharmaphorum’s Deep Dive digital magazine. Clinical trial design. Product support and information.

article thumbnail

How to Maximize ROI in B2B Healthcare Marketing

Scott’s Directories

The healthcare industry is a dynamic and ever-evolving field that demands effective marketing strategies to stay ahead of the competition. In today’s fast-paced world, reaching the right audience at the right time is crucial for B2B healthcare marketing success.

article thumbnail

Realising the promise of genomic testing across oncology

pharmaphorum

“There has been a surge in the number of biomarkers discovered through a broader understanding of the molecular pathways involved in the development of cancer, both across solid and liquid tumours,” explains Orlaith Brennan, market development director, Patient & Market Access at IQVIA. “In